Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Clinical trial NCT04581473 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04581473
- Sponsor
- CARsgen Therapeutics Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2024-10-18
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.